RECRUITING

Virtual Reality Devices As an Adjunct to Usual Care for Patients with Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Conditions

Sickle Cell Disease Vaso-occlusive Pain Episode in Sickle Cell Disease Acute Pain

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.

Official Title

Pilot Study to Investigate the Use of Virtual Reality Devices As an Adjunct to Usual Care for Patients with Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Quick Facts

Study Start:2024-11

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06184126

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Adult (age \> 18 years) emergency department patient * History of sickle cell disease * Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis	* Prior enrollment in this study * Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider * Not being treated with intravenous opioids for the vaso-occlusive crisis * Patients who lack the capacity to provide informed consent * Medical history of seizures or known intolerance to virtual reality * Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device. * Known to be pregnant * Incarcerated at the time of evaluation * Over the age of 89 years old

Inclusion Criteria

Exclusion Criteria

* Adult (age \> 18 years) emergency department patient
* History of sickle cell disease
* Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis

* Prior enrollment in this study
* Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
* Not being treated with intravenous opioids for the vaso-occlusive crisis
* Patients who lack the capacity to provide informed consent
* Medical history of seizures or known intolerance to virtual reality
* Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
* Known to be pregnant
* Incarcerated at the time of evaluation
* Over the age of 89 years old

Contacts and Locations

Study Contact

R. Gentry Wilkerson, MD

CONTACT

410-328-4237

gwilkerson@som.umaryland.edu

Principal Investigator

R. Gentry Wilklerson, MD

PRINCIPAL_INVESTIGATOR

U of Maryland, Baltimore

Study Locations (Sites)

University of Maryland Medical Systems

Baltimore, Maryland, 21201

United States

Collaborators and Investigators

Sponsor: University of Maryland, Baltimore

R. Gentry Wilklerson, MD, PRINCIPAL_INVESTIGATOR, U of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-11

Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

Sickle Cell Disease
Vaso-occlusive Pain Episode in Sickle Cell Disease
Acute Pain